BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20888325)

  • 1. DNA strand breaks and hypoxia response inhibition mediate the radiosensitisation effect of nitric oxide donors on prostate cancer under varying oxygen conditions.
    Stewart GD; Nanda J; Katz E; Bowman KJ; Christie JG; Brown DJ; McLaren DB; Riddick AC; Ross JA; Jones GD; Habib FK
    Biochem Pharmacol; 2011 Jan; 81(2):203-10. PubMed ID: 20888325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NO-sulindac inhibits the hypoxia response of PC-3 prostate cancer cells via the Akt signalling pathway.
    Stewart GD; Nanda J; Brown DJ; Riddick AC; Ross JA; Habib FK
    Int J Cancer; 2009 Jan; 124(1):223-32. PubMed ID: 18924134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition.
    Jonsson M; Ragnum HB; Julin CH; Yeramian A; Clancy T; Frikstad KM; Seierstad T; Stokke T; Matias-Guiu X; Ree AH; Flatmark K; Lyng H
    Br J Cancer; 2016 Oct; 115(8):929-939. PubMed ID: 27599042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
    Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
    Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells.
    Zou C; Yu S; Xu Z; Wu D; Ng CF; Yao X; Yew DT; Vanacker JM; Chan FL
    J Pathol; 2014 May; 233(1):61-73. PubMed ID: 24425001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of hypoxia-inducible factor 1α accumulation by glyceryl trinitrate and cyclic guanosine monophosphate.
    Kim J; Barsoum IB; Loh H; Paré JF; Siemens DR; Graham CH
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31912870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microtubule-targeting-compound PBOX-15 radiosensitizes cancer cells in vitro.
    Forde JC; Maginn EN; McNamara G; Martin LM; Campiani G; Williams DC; Zisterer D; McElligott AM; Lawler M; Lynch TH; Hollywood D; Marignol L
    Cancer Biol Ther; 2011 Feb; 11(4):421-8. PubMed ID: 21131779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bortezomib enhances the radiosensitivity of hypoxic cervical cancer cells by inhibiting HIF-1α expression.
    Cui H; Qin Q; Yang M; Zhang H; Liu Z; Yang Y; Chen X; Zhu H; Wang D; Meng C; Song H; Ma J; Huang G; Cai J; Sun X; Wang Z
    Int J Clin Exp Pathol; 2015; 8(8):9032-41. PubMed ID: 26464645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-145 Modulates Tumor Sensitivity to Radiation in Prostate Cancer.
    Gong P; Zhang T; He D; Hsieh JT
    Radiat Res; 2015 Dec; 184(6):630-8. PubMed ID: 26632856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay.
    Marampon F; Gravina GL; Zani BM; Popov VM; Fratticci A; Cerasani M; Di Genova D; Mancini M; Ciccarelli C; Ficorella C; Di Cesare E; Festuccia C
    Int J Oncol; 2014 Jun; 44(6):2121-31. PubMed ID: 24676782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous nitric oxide potentiate DNA damage and alter DNA repair in cells exposed to ionising radiation.
    Mikhailenko VM; Muzalov II
    Exp Oncol; 2013 Dec; 35(4):318-24. PubMed ID: 24382445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of 2-methoxyestradiol-induced cytotoxicity by blocking endothelin A receptor in prostate cancer cells.
    Mabjeesh NJ; Shefler A; Amir S; Matzkin H
    Prostate; 2008 May; 68(6):679-89. PubMed ID: 18288682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased growth factor production in a human prostatic stromal cell culture model caused by hypoxia.
    Berger AP; Kofler K; Bektic J; Rogatsch H; Steiner H; Bartsch G; Klocker H
    Prostate; 2003 Sep; 57(1):57-65. PubMed ID: 12886524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reoxygenation of human coronary smooth muscle cells suppresses HIF-1alpha gene expression and augments radiation-induced growth delay and apoptosis.
    Grumann T; Arab A; Bode C; Guttenberger R; Hehrlein C
    Strahlenther Onkol; 2006 Jan; 182(1):16-21. PubMed ID: 16404516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1alpha and HIF-2alpha in prostate cancer cells.
    Palayoor ST; Tofilon PJ; Coleman CN
    Clin Cancer Res; 2003 Aug; 9(8):3150-7. PubMed ID: 12912967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repair of DNA and chromosome breaks in cells exposed to SR 4233 under hypoxia or to ionizing radiation.
    Wang J; Biedermann KA; Brown JM
    Cancer Res; 1992 Aug; 52(16):4473-7. PubMed ID: 1643639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel poly(ADP-ribose) polymerase inhibitor, ABT-888, radiosensitizes malignant human cell lines under hypoxia.
    Liu SK; Coackley C; Krause M; Jalali F; Chan N; Bristow RG
    Radiother Oncol; 2008 Aug; 88(2):258-68. PubMed ID: 18456354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of motexafin gadolinium on DNA damage and X-ray-induced DNA damage repair, as assessed by the Comet assay.
    Donnelly ET; Liu Y; Paul TK; Rockwell S
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1176-86. PubMed ID: 15990023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ion channel TRPM8 promotes hypoxic growth of prostate cancer cells via an O2 -independent and RACK1-mediated mechanism of HIF-1α stabilization.
    Yu S; Xu Z; Zou C; Wu D; Wang Y; Yao X; Ng CF; Chan FL
    J Pathol; 2014 Dec; 234(4):514-25. PubMed ID: 25065497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of PC-1/PrLZ sensitizes prostate cancer cells to ionizing radiation by attenuating DNA damage repair and inducing autophagic cell death.
    Shang ZF; Wei Q; Yu L; Huang F; Xiao BB; Wang H; Song M; Wang L; Zhou J; Wang J; Li S
    Oncotarget; 2016 Sep; 7(38):62340-62351. PubMed ID: 27694690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.